company background image
PACB

Pacific Biosciences of California NasdaqGS:PACB Stock Report

Last Price

US$11.25

Market Cap

US$2.9b

7D

-2.0%

1Y

-4.6%

Updated

08 Feb, 2023

Data

Company Financials +

Pacific Biosciences of California, Inc.

NasdaqGS:PACB Stock Report

Mkt Cap: US$2.9b

PACB Stock Overview

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.

PACB fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health3/6
Dividends0/6

My Notes

New

Notes are coming soon

Pacific Biosciences of California, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pacific Biosciences of California
Historical stock prices
Current Share PriceUS$11.25
52 Week HighUS$14.20
52 Week LowUS$3.85
Beta1.66
1 Month Change18.92%
3 Month Change12.28%
1 Year Change-4.58%
3 Year Change164.71%
5 Year Change355.47%
Change since IPO-31.57%

Recent News & Updates

Recent updates

Time To Worry? Analysts Just Downgraded Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Outlook

Aug 08
Time To Worry? Analysts Just Downgraded Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Outlook

Pacific Biosciences: A Prime Candidate For My 'Bio Boom' Portfolio

Jul 27

Is Pacific Biosciences of California (NASDAQ:PACB) Using Debt Sensibly?

Jul 11
Is Pacific Biosciences of California (NASDAQ:PACB) Using Debt Sensibly?

Pacific Biosciences Hit By Sentiment, But The Future Of Long-Read Sequencing Is Strong

Apr 05

Is Pacific Biosciences of California (NASDAQ:PACB) Using Too Much Debt?

Feb 24
Is Pacific Biosciences of California (NASDAQ:PACB) Using Too Much Debt?

Is Pacific Biosciences of California (NASDAQ:PACB) Weighed On By Its Debt Load?

Nov 26
Is Pacific Biosciences of California (NASDAQ:PACB) Weighed On By Its Debt Load?

10% Short Interest In Pacific Biosciences Makes Sense

Nov 20

Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside

Aug 04

Is Pacific Biosciences of California (NASDAQ:PACB) Using Too Much Debt?

Jun 01
Is Pacific Biosciences of California (NASDAQ:PACB) Using Too Much Debt?

The Pullback In Pacific Biosciences Makes For A Much More Interesting Opportunity

May 26

Pacific Biosciences of California's (NASDAQ:PACB) Earnings Are Built On Soft Foundations

Mar 05
Pacific Biosciences of California's (NASDAQ:PACB) Earnings Are Built On Soft Foundations

Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Intrinsic Value Is Potentially 25% Below Its Share Price

Jan 28
Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Intrinsic Value Is Potentially 25% Below Its Share Price

PacBio, Invitae team up to develop genome-based testing offerings

Jan 13

Pacific Biosciences of California creates two new management roles

Jan 08

What Kind Of Shareholders Hold The Majority In Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Shares?

Dec 21
What Kind Of Shareholders Hold The Majority In Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) Shares?

Don't Be Fooled By Pacific Biosciences' Accounting Of Merger Termination With Illumina

Dec 15

Shareholder Returns

PACBUS Life SciencesUS Market
7D-2.0%1.5%1.6%
1Y-4.6%-12.5%-10.8%

Return vs Industry: PACB exceeded the US Life Sciences industry which returned -12.5% over the past year.

Return vs Market: PACB exceeded the US Market which returned -10.8% over the past year.

Price Volatility

Is PACB's price volatile compared to industry and market?
PACB volatility
PACB Average Weekly Movement12.9%
Life Sciences Industry Average Movement11.6%
Market Average Movement6.7%
10% most volatile stocks in US Market17.4%
10% least volatile stocks in US Market2.8%

Stable Share Price: PACB is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: PACB's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2000728Christian O. Henryhttps://www.pacb.com

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio’s Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides.

Pacific Biosciences of California, Inc. Fundamentals Summary

How do Pacific Biosciences of California's earnings and revenue compare to its market cap?
PACB fundamental statistics
Market CapUS$2.94b
Earnings (TTM)-US$299.19m
Revenue (TTM)US$136.97m

21.4x

P/S Ratio

-9.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PACB income statement (TTM)
RevenueUS$136.97m
Cost of RevenueUS$75.58m
Gross ProfitUS$61.39m
Other ExpensesUS$360.59m
Earnings-US$299.19m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 16, 2023

Earnings per share (EPS)-1.15
Gross Margin44.82%
Net Profit Margin-218.44%
Debt/Equity Ratio143.1%

How did PACB perform over the long term?

See historical performance and comparison